Quick Answer
Drugs Made In America Acquisition Corp. reported Shares Outstanding of 9.86 million shares for fiscal year 2024.
Drugs Made In America Acquisition Corp. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 9.86M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 10.52M | — | +0.0% |
| June 30, 2025 | 10.52M | — | +0.0% |
| March 31, 2025 | 10.52M | — | +6.7% |
| December 31, 2024 | 9.86M | — | — |
- The most recent figure is from Drugs Made In America Acquisition Corp.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: